Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Bausch + Lomb buys J&J's dry eye relief drops for $107 mln
07:24am, Thursday, 06'th Jul 2023
Bausch + Lomb said on Thursday it has acquired Johnson & Johnson's eye and contact lens drops for $106.5 million in an all-cash deal to expand its portfolio of over-the-counter eye care products.
Where to Invest $1,000 Right Now
02:00pm, Wednesday, 05'th Jul 2023
It's important to consider your comfort level with risk before getting started. Plenty of exciting investment options exist today, whether you're a cautious or aggressive investor.
3 Spectacular Dividend Stocks to Buy in July
08:14am, Tuesday, 04'th Jul 2023
AbbVie is a Dividend King with a high yield. Bristol Myers Squibb is an underrated bargain.
3 Long-Term Stocks to Make Your ‘Get Rich' Dreams Come True
03:59pm, Monday, 03'rd Jul 2023
Building long-term wealth requires patience. Instead of short-term trading, it requires finding companies that can compound for decades.
3 Dividend Stocks to Buy Right This Minute
04:34pm, Friday, 30'th Jun 2023
Since the second half of 2022, the economy has been volatile and this has led to many investors looking for safe and stable stocks to invest in. The market was in a rout and no industry has been spare
Like shoppers, IPO investors are demanding discounts and showing price sensitivity
12:17pm, Friday, 30'th Jun 2023
IPO investors, much like shoppers in the current inflationary environment, are demanding clear discounts and demonstrating sensitivity to price and valuations, according to Renaissance Capital.
Ranking These 5 Dividend Kings From Highest Quality To Lowest
09:38am, Friday, 30'th Jun 2023
The article ranks 5 Dividend Kings, from highest to lowest quality. A Dividend King is any stock that has raised their dividend for 50+ consecutive years, making them the most consistent dividend paye
5 Genius Safe Stocks to Buy for the Second Half of 2023
05:21am, Friday, 30'th Jun 2023
Although the S&P 500 and Nasdaq Composite have bounced back in a big way in 2023, there's no guarantee the upward momentum has legs. Five rock-solid companies with well-defined competitive advantages
Johnson & Johnson: Buy The Market (Technical Analysis)
11:26pm, Thursday, 29'th Jun 2023
Johnson & Johnson is strategically shifting towards high-growth sectors like pharmaceuticals and medical devices. Technical analysis of JNJ's stock price shows a strong bullish trend, indicating the p
Johnson & Johnson: Pay Yourself 7% With This Bond-Like Exposure
03:31pm, Thursday, 29'th Jun 2023
Johnson & Johnson: Pay Yourself 7% With This Bond-Like Exposure
Is Johnson & Johnson Stock a Strong Buy?
02:00pm, Thursday, 29'th Jun 2023
Despite a top-shelf dividend and an elite innovation engine, J&J stock has lagged the broader markets since 2017. With a strong near-term outlook, J&J ought to deliver better results for shareholders
Where Will Johnson & Johnson Be in 5 Years?
10:07am, Thursday, 29'th Jun 2023
Johnson & Johnson's sales growth has not been impressive in recent years. If it can resolve its talc lawsuits, perhaps J&J can pursue more acquisitions.
5 High-Yielding Dividend Stocks That Are Bargain Buys
10:00am, Thursday, 29'th Jun 2023
Some of the biggest names in healthcare are on sale right now. J&J, AbbVie, Bristol Myers, Amgen, and Pfizer all trade at low valuations.
The 3 Most Undervalued Dow Stocks to Buy Now: June 2023
08:27am, Thursday, 29'th Jun 2023
The Dow Jones Industrial Average has not exactly been keeping up with the other indices so far this year. That fact has left behind a number of undervalued Dow stocks for value investing.
Retire Rich With 'Dividend King' Royalty
07:00am, Thursday, 29'th Jun 2023
As my readers know, I'm no market timer, I'm a value investor. Regardless of what Fed Chair Jerome Powell is telling us, I'm confident that the rate-hike cycle is going to end (sooner rather than late
